DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/5a6ace/molecular_diagnost) has announced the addition of Jain PharmaBiotech's new report "Molecular Diagnostics - Technologies, Markets and Companies" to their extensive offering of medical research publications.
Molecular Diagnostics - Technologies, Markets and Companies examines the molecular diagnostics technologies that will play an important role in practice of medicine, public health, pharmaceutical industry, forensics and biological warfare in the 21st century.
The authors at Jain PharmaBiotech find that initial applications of molecular diagnostics were mostly for infections but are now increasing in the areas of genetic disorders, preimplantation screening and cancer. Genetic screening tests, despite some restrictions, is a promising area for future expansion of in vitro diagnostic market. Molecular diagnostics is being combined with therapeutics and forms an important component of integrated healthcare. Molecular diagnostic technologies are also involved in development of personalized medicine based on pharmacogenetics and pharmacogenomics. Currently, there has been a considerable interest in developing rapid diagnostic methods for point-of-care and biowarfare agents such as anthrax.
More than 500 companies are developing molecular diagnostics and 312 of these are profiled in the report along with tabulation of 699 collaborations. Despite the strict regulation, most of the development in molecular diagnostics has taken place in the United States, which has the largest number of companies.
2010 molecular diagnostic markets are analyzed according to technologies, applications and geographical regions. Forecasts are made up to 2020. A major portion of the molecular diagnostic market can be attributed to advances in genomics and proteomics, but biochip and nanobiotechnology are expected to make a significant contribution to market growth.
Benefits of this report:
- This report has evolved during the past 15 years, profiting from feedback by numerous readers and experts.
- The most comprehensive and up-to-date one-stop source of information on technical and commercial aspects of molecular diagnostics.
- Includes profiles of 312 companies, the largest number in any report on this topic.
- 500 references, cited in the report are included in the bibliography.
- The text is supplemented by 97 tables and 15 figures.
For more information visit http://www.researchandmarkets.com/research/5a6ace/molecular_diagnost